A. Hague et al., DECREASED LEVELS OF P26-BCL-2, BUT NOT P-30 PHOSPHORYLATED BCL-2, PRECEDE TGF-BETA(1)-INDUCED APOPTOSIS IN COLORECTAL ADENOMA CELLS, Carcinogenesis (New York. Print), 19(9), 1998, pp. 1691-1695
Bcl-2 expression is confined to the base of the colonic crypt, whereas
transforming growth factor beta (TGF beta) is expressed in the upper
crypt, as are the apoptotic death promoters, Bah and Bar. In colonic a
denoma cells, TGF beta induces a growth arrest. In some adenoma cell l
ines, this is accompanied by apoptosis and in others it is not. In thi
s study, we used two human colonic adenoma cell lines: RG/C2, in which
TGF beta induces a G(1) arrest without apoptosis, and BH/C1, in which
TGF beta induces both a GI arrest and apoptosis, TGF beta does not in
duce apoptosis in RG/C2 cells even if hydrocortisone and insulin are r
emoved from the culture medium. In BH/C1 cells, TGF beta induces apopt
osis in the presence of insulin and hydrocortisone. Apoptosis induced
by TGF beta is preceded by a reduction in p26-Bcl-2 protein levels, Th
ere was no change in the levels of the p30 phosphorylated form of Bcl-
2 or in levels of the pro-apoptotic proteins Bar or Bah, RG/C2 cells d
id not show decreased Bcl-2 levels in response to TGF beta-induced gro
wth inhibition. Therefore, TGF beta regulates Bcl-2 expression in colo
nic adenoma cells which undergo apoptosis in response to TGF beta, but
not in those which are growth inhibited, but resistant to TGF beta-in
duced apoptosis, TGF beta may play an important role in the colonic ep
ithelium, not only in the inhibition of cell proliferation, but also i
n the regulation of apoptosis.